FDA rejects energy drink petition
The agency denies a citizen petition requesting enhanced labeling requirements for energy drinks due to a lack of information providing "an adequate basis for the issuance of regulations that identify specific labeling requirements for sports and energy beverages." The April 2002 petition submitted by Arthur Blank maintains that energy drinks should be labeled with a statement of the product's osmolality and tonicity - qualities denoting how readily the beverage is absorbed into the blood stream. Such labeling would give consumers "a better understanding of that product's capabilities of performing." FDA's response, posted Feb. 13, says Blank fails to show how the labeling requirements would promote the public interest or the objectives of the Food, Drug and Cosmetic Act
More from Archive
More from Pink Sheet
Recognizing that the evidence it receives in applications for health technology assessments will increasingly be informed by artificial intelligence, the CDA-AMC has clarified its expectations for companies that use AI methods in the generation and/or reporting of evidence.
Plozasiran, Arrowhead Pharmaceuticals' treatment for familial chylomicronemia syndrome, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
DIA Korea hears how multiple domestic and global factors are affecting the environment for clinical trials in South Korea, and what actions may be taken to address this.